Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1945 1
1946 4
1947 11
1948 12
1949 10
1950 16
1951 14
1952 18
1953 24
1954 18
1955 14
1956 18
1957 18
1958 9
1959 14
1960 30
1961 21
1962 25
1963 59
1964 103
1965 70
1966 67
1967 55
1968 82
1969 81
1970 68
1971 73
1972 86
1973 78
1974 98
1975 99
1976 64
1977 117
1978 88
1979 113
1980 85
1981 107
1982 98
1983 104
1984 118
1985 110
1986 116
1987 122
1988 135
1989 136
1990 125
1991 125
1992 115
1993 89
1994 111
1995 95
1996 96
1997 111
1998 96
1999 88
2000 97
2001 96
2002 134
2003 126
2004 148
2005 197
2006 210
2007 241
2008 223
2009 241
2010 268
2011 254
2012 310
2013 344
2014 381
2015 439
2016 476
2017 443
2018 431
2019 420
2020 445
2021 511
2022 479
2023 463
2024 357

Text availability

Article attribute

Article type

Publication date

Search Results

10,663 results

Results by year

Filters applied: . Clear all
Page 1
Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management.
Tefferi A. Tefferi A. Am J Hematol. 2023 May;98(5):801-821. doi: 10.1002/ajh.26857. Epub 2023 Feb 6. Am J Hematol. 2023. PMID: 36680511 Free article. Review.
DISEASE OVERVIEW: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal myeloproliferation that is often but not always accompanied by JAK2, CALR, or MPL mutations; additional features include bone marrow reticu …
DISEASE OVERVIEW: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal …
Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management.
Tefferi A. Tefferi A. Am J Hematol. 2021 Jan;96(1):145-162. doi: 10.1002/ajh.26050. Epub 2020 Dec 2. Am J Hematol. 2021. PMID: 33197049 Free article. Review.
DISEASE OVERVIEW: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal myeloproliferation that is often but not always accompanied by JAK2, CALR, or MPL mutations. ...DIAGNOSIS: Bone marrow morphology is the …
DISEASE OVERVIEW: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal …
[Myelofibrosis: A review].
Genthon A, Killian M, Mertz P, Cathebras P, Gimenez De Mestral S, Guyotat D, Chalayer E. Genthon A, et al. Rev Med Interne. 2021 Feb;42(2):101-109. doi: 10.1016/j.revmed.2020.08.018. Epub 2020 Nov 23. Rev Med Interne. 2021. PMID: 33243417 Review. French.
Myelofibrosis is a BCR-ABL1-negative chronic myeloproliferative neoplasm that includes primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis. ...Complications as thromboembolic or hemorrhag …
Myelofibrosis is a BCR-ABL1-negative chronic myeloproliferative neoplasm that includes primary myelofibrosis, post-poly …
Myelofibrosis biology and contemporary management.
Gangat N, Tefferi A. Gangat N, et al. Br J Haematol. 2020 Oct;191(2):152-170. doi: 10.1111/bjh.16576. Epub 2020 Mar 20. Br J Haematol. 2020. PMID: 32196650 Free article. Review.
Myelofibrosis is an enigmatic myeloproliferative neoplasm, despite noteworthy strides in understanding its genetic underpinnings. ...Presently, prognostic assessment tools for primary myelofibrosis (PMF) are centered on genetics, with incorporation of cytogen …
Myelofibrosis is an enigmatic myeloproliferative neoplasm, despite noteworthy strides in understanding its genetic underpinnings. ... …
A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management.
Garmezy B, Schaefer JK, Mercer J, Talpaz M. Garmezy B, et al. Blood Rev. 2021 Jan;45:100691. doi: 10.1016/j.blre.2020.100691. Epub 2020 Apr 7. Blood Rev. 2021. PMID: 32354563 Review.
Although understanding of the pathogenesis and molecular biology of primary myelofibrosis continues to improve, treatment options are limited, and several biological features remain unexplained. ...In this review, we outline what is known about the disease pathogene …
Although understanding of the pathogenesis and molecular biology of primary myelofibrosis continues to improve, treatment opti …
Myelofibrosis Treatment Algorithm 2018.
Tefferi A, Guglielmelli P, Pardanani A, Vannucchi AM. Tefferi A, et al. Blood Cancer J. 2018 Jul 31;8(8):72. doi: 10.1038/s41408-018-0109-0. Blood Cancer J. 2018. PMID: 30065290 Free PMC article. Review.
Two novel prognostic systems for primary myelofibrosis (PMF) were recently unveiled: GIPSS (genetically inspired prognostic scoring system) and MIPSS70 (mutation-enhanced international prognostic scoring system for transplant-age patients). ...
Two novel prognostic systems for primary myelofibrosis (PMF) were recently unveiled: GIPSS (genetically inspired prognostic sc …
State-of-the-Art Review on Myelofibrosis Therapies.
Wang F, Qiu T, Wang H, Yang Q. Wang F, et al. Clin Lymphoma Myeloma Leuk. 2022 May;22(5):e350-e362. doi: 10.1016/j.clml.2021.11.007. Epub 2021 Nov 15. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34903489 Review.
Myelofibrosis (MF) is a BCR-ABL1-negative myeloproliferative neoplasm characterized by anemia, extramedullary hematopoiesis, bone marrow fibrosis, splenomegaly, constitutional symptoms and acute myeloid leukemia progression. ...
Myelofibrosis (MF) is a BCR-ABL1-negative myeloproliferative neoplasm characterized by anemia, extramedullary hematopoiesis, bone mar …
Myelofibrosis: clinicopathologic features, prognosis, and management.
O'Sullivan JM, Harrison CN. O'Sullivan JM, et al. Clin Adv Hematol Oncol. 2018 Feb;16(2):121-131. Clin Adv Hematol Oncol. 2018. PMID: 29741513 Review.
Myelofibrosis is one of the BCR-ABL-negative clonal disorders that collectively are known as myeloproliferative neoplasms (MPNs). ...This review provides further detail regarding the clinical features, pathogenesis, risk stratification, and current management of myelofi …
Myelofibrosis is one of the BCR-ABL-negative clonal disorders that collectively are known as myeloproliferative neoplasms (MPNs). ... …
Novel therapeutics and targets in myelofibrosis.
Waksal JA, Harrison CN, Mascarenhas JO. Waksal JA, et al. Leuk Lymphoma. 2022 May;63(5):1020-1033. doi: 10.1080/10428194.2021.2010068. Epub 2021 Dec 2. Leuk Lymphoma. 2022. PMID: 34852713 Review.
Myelofibrosis is a myeloproliferative neoplasm characterized by clonal proliferation of myeloid cells, bone marrow fibrosis and cytopenias, extramedullary hematopoiesis and hepatosplenomegaly, increased pro-inflammatory cytokine production, and systemic symptoms. ...Despit …
Myelofibrosis is a myeloproliferative neoplasm characterized by clonal proliferation of myeloid cells, bone marrow fibrosis and cytop …
10,663 results
You have reached the last available page of results. Please see the User Guide for more information.